A Study of CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite Immunosuppressants (Breakfree-SLE)
for Lupus Erythematosus, Systemic
Drug: BMS-986353
40 locations incl. Scottsdale
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Sex: All·Age: 16+
Code: NCT07015983·Phase 2·Recruiting